Investors in Stericycle, Inc. (NASDAQ:SRCL) had a good week, as its shares rose 6.7% to close at US$53.77 following the release of its yearly results. Revenues were in line with expectations, at US$2.7b, while statutory losses ballooned to US$0.23 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
View our latest analysis for Stericycle
Taking into account the latest results, the consensus forecast from Stericycle’s eight analysts is for revenues of US$2.73b in 2024. This reflects a satisfactory 2.7% improvement in revenue compared to the last 12 months. Stericycle is also expected to turn profitable, with statutory earnings of…
